About Albemarle (NYSE:ALB)
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions. The bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Company serves various end markets, including petroleum refining, consumer electronics, energy storage, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services. As of December 31, 2016, the Company and its joint ventures operated 31 production and research and development (R&D) facilities, as well as a number of administrative and sales offices, around the world.
Industry, Sector and Symbol
Trailing P/E Ratio21.38
Forward P/E Ratio19.25
Sales & Book Value
Annual Sales$3.07 billion
Price / Sales3.54
Cash Flow$6.45 per share
Price / Cash15.25
Book Value$34.55 per share
Price / Book2.85
Net Income$54.85 million
Return on Equity13.27%
Return on Assets6.89%
Albemarle (NYSE:ALB) Frequently Asked Questions
What is Albemarle's stock symbol?
Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."
How often does Albemarle pay dividends? What is the dividend yield for Albemarle?
Albemarle announced a quarterly dividend on Friday, February 23rd. Investors of record on Thursday, March 15th will be given a dividend of $0.335 per share on Monday, April 2nd. This represents a $1.34 annualized dividend and a dividend yield of 1.36%. The ex-dividend date is Wednesday, March 14th. This is a positive change from Albemarle's previous quarterly dividend of $0.32. View Albemarle's Dividend History.
How were Albemarle's earnings last quarter?
Albemarle Co. (NYSE:ALB) posted its quarterly earnings data on Tuesday, February, 27th. The specialty chemicals company reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.13. The specialty chemicals company earned $857.79 million during the quarter, compared to the consensus estimate of $791.46 million. Albemarle had a net margin of 1.79% and a return on equity of 13.27%. View Albemarle's Earnings History.
When will Albemarle make its next earnings announcement?
What guidance has Albemarle issued on next quarter's earnings?
Albemarle updated its FY18 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of $5.00-5.40 for the period, compared to the Thomson Reuters consensus estimate of $5.14. The company issued revenue guidance of $3.2-3.4 billion, compared to the consensus revenue estimate of $3.23 billion.
Where is Albemarle's stock going? Where will Albemarle's stock price be in 2018?
22 equities research analysts have issued 1-year price targets for Albemarle's stock. Their predictions range from $36.00 to $157.00. On average, they anticipate Albemarle's stock price to reach $125.53 in the next twelve months. View Analyst Ratings for Albemarle.
What are Wall Street analysts saying about Albemarle stock?
Here are some recent quotes from research analysts about Albemarle stock:
- 1. KeyCorp analysts commented, "ITRI beat 4Q17 consensus on top/bottom line while guiding FY18 adj. EPS midpoint 2% below Street. Amid moving parts—Silver Spring (now “Networks”) integration, a new restructuring program, and ongoing impacts from 2016 restructuring—we have three primary takeaways. First, we think FY18 guidance embeds healthy organic growth at legacy Itron, supported by 12-month backlog up 22%. Second, we see revenue recog. timing at Networks as a potential dilutive factor in FY18 guidance (on top of Networks’ already higher cost structure) that understates margin expansion at legacy Itron. Third, we believe the restructuring plan is mainly a continuation of existing optimization programs and supports our view of the long-term adj. EBITDA trajectory (which moves slightly lower along with our PT to $77). Maintain Outperform." (3/1/2018)
- 2. According to Zacks Investment Research, "Albemarle has outperformed the industry it belongs to over a year. Albemarle remains focused on strengthening its lithium business. It is well placed to leverage strong expected growth in the battery-grade lithium market. The company should also gain from the synergies of Rockwood Holdings acquisition. Albemarle is also divesting non-core assets to boost growth opportunities and focus on its key businesses. Moreover, the company remains committed to deliver incremental returns to shareholders. However, Albemarle faces headwinds associated with higher expected operational costs and high tax rate in 2017. Moreover, unfavorable impacts of Hurricane Harvey may continue to affect its results." (12/19/2017)
- 3. UBS analysts commented, "Theme was 'potential 'drives everything ALB does'. Batteries store potential energy chemically, until needed to create electrical potential to power devices. Lithium chem. is the primary driver of ALB earnings growth. 2021 targets were introduced for 7-10% organic sales CAGR, primarily from lithium. Average EBITDA margins also targeted to reach 32-35% (vs. 29% 2017e), implying an EBITDA CAGR of 9%-15% (primarily from lithium, which improves margin mix)." (3/22/2017)
Who are some of Albemarle's key competitors?
Some companies that are related to Albemarle include Asahi Kasei (AHKSY), DSM (RDSMY), Eastman Chemical (EMN), Westlake Chemical (WLK), Mitsubishi Chemical (MTLHY), Celanese (CE), Novozymes A/S (NVZMY), FMC (FMC), International Flavors & Fragrances (IFF), Arkema (ARKAY), Brenntag AG, Muehleim/Ruhr (BNTGY), Chemours (CC), Johnson Matthey (JMPLY), Axalta Coating Systems (AXTA), Huntsman (HUN), Sinopec Shanghai Petrochemical (SHI), Tosoh (TOSCF) and Nissan Chemical Industries (NNCHY).
Who are Albemarle's key executives?
Albemarle's management team includes the folowing people:
- Luther C. Kissam IV, Chairman, President and Chief Executive Officer (Age 52)
- Scott A. Tozier, Chief Financial Officer, Executive Vice President (Age 51)
- Karen G. Narwold, Executive Vice President, Chief Administrative Officer (Age 57)
- Donald J. LaBauve Jr., Chief Accounting Officer, Vice President, Corporate Controller (Age 50)
- Eric W. Norris, Chief Strategy Officer (Age 50)
- Jimmy W. Nokes, Lead Independent Director (Age 70)
- Laurie Brlas, Director
- William H. Hernandez, Independent Director (Age 68)
- Douglas L. Maine, Independent Director (Age 68)
- Jerry Kent Masters, Independent Director (Age 57)
Who owns Albemarle stock?
Albemarle's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Franklin Resources Inc. (8.18%), BlackRock Inc. (7.30%), Jennison Associates LLC (7.13%), Bank of New York Mellon Corp (3.88%), TIAA CREF Investment Management LLC (1.58%) and Global X Management Co. LLC (1.36%). Company insiders that own Albemarle stock include Donald J Jr Labauve, Douglas L Maine, John Sherman Jr, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.
Who sold Albemarle stock? Who is selling Albemarle stock?
Albemarle's stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Bank of New York Mellon Corp, Guggenheim Capital LLC, OppenheimerFunds Inc., Teachers Advisors LLC, Barometer Capital Management Inc., KAMES CAPITAL plc and AGF Investments Inc.. Company insiders that have sold Albemarle company stock in the last year include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Insider Buying and Selling for Albemarle.
Who bought Albemarle stock? Who is buying Albemarle stock?
Albemarle's stock was acquired by a variety of institutional investors in the last quarter, including Global X Management Co. LLC, Arrowstreet Capital Limited Partnership, Barings LLC, Allianz Asset Management GmbH, Clifford Swan Investment Counsel LLC, First Trust Advisors LP, Jennison Associates LLC and BlackRock Inc.. View Insider Buying and Selling for Albemarle.
How do I buy Albemarle stock?
Shares of Albemarle can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Albemarle's stock price today?
One share of Albemarle stock can currently be purchased for approximately $98.37.
How big of a company is Albemarle?
Albemarle has a market capitalization of $10.88 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $0.48 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.
How can I contact Albemarle?
Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700.
MarketBeat Community Rating for Albemarle (ALB)MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Albemarle (NYSE:ALB) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.77||2.65||2.63||2.81|
|Ratings Breakdown: ||0 Sell Rating(s)|
5 Hold Rating(s)
17 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
7 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
4 Hold Rating(s)
11 Buy Rating(s)
1 Strong Buy Rating(s)
|Consensus Price Target: ||$125.53||$125.18||$125.67||$112.31|
|Price Target Upside: ||27.61% upside||14.63% upside||12.35% downside||11.77% downside|
Albemarle (NYSE:ALB) Consensus Price Target History
Albemarle (NYSE:ALB) Analyst Ratings History
(Data available from 3/18/2016 forward)
Albemarle (NYSE:ALB) Earnings History and Estimates Chart
Albemarle (NYSE ALB) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/27/2018||Q4 2017||$1.21||$1.34||$791.46 million||$857.79 million||View||Listen|
|11/8/2017||Q3 2017||$1.07||$1.08||$732.19 million||$755.00 million||View||N/A|
|8/7/2017||Q2 2017||$1.11||$1.13||$735.50 million||$737.25 million||View||Listen|
|5/3/2017||Q1 2017||$0.95||$1.05||$678.74 million||$722.06 million||View||Listen|
|2/27/2017||Q416||$0.73||$0.78||$642.68 million||$696.70 million||View||Listen|
|11/7/2016||Q316||$0.81||$0.91||$645.81 million||$654.00 million||View||Listen|
|8/3/2016||Q216||$1.00||$1.09||$860.40 million||$669.30 million||View||Listen|
|5/10/2016||Q116||$0.86||$1.12||$821.64 million||$865.40 million||View||Listen|
|2/17/2016||Q415||$0.83||$1.03||$891.88 million||$930.40 million||View||Listen|
|11/4/2015||Q315||$0.89||$0.90||$950.25 million||$905.10 million||View||Listen|
|8/5/2015||Q215||$0.82||$0.84||$940.65 million||$931.50 million||View||Listen|
|5/6/2015||Q115||$0.71||$1.17||$913.20 million||$884.40 million||View||Listen|
|1/28/2015||Q414||$1.01||$0.99||$638.76 million||$598.00 million||View||Listen|
|10/22/2014||Q314||$1.02||$1.14||$617.70 million||$642.40 million||View||Listen|
|7/30/2014||Q214||$1.09||$1.10||$646.75 million||$604.70 million||View||Listen|
|4/16/2014||Q114||$0.95||$0.96||$655.87 million||$656.70 million||View||Listen|
|1/29/2014||Q413||$1.21||$1.08||$688.58 million||$692.00 million||View||Listen|
|10/17/2013||Q313||$1.08||$1.09||$655.97 million||$648.80 million||View||Listen|
|7/17/2013||Q2 2013||$0.98||$0.97||$654.31 million||$634.20 million||View||Listen|
|4/17/2013||Q1 2013||$1.02||$0.93||$681.09 million||$641.60 million||View||Listen|
|1/22/2013||Q4 2012||$0.98||$1.17||$646.83 million||$687.60 million||View||Listen|
Albemarle (NYSE:ALB) Earnings Estimates
2018 EPS Consensus Estimate: $5.14
2019 EPS Consensus Estimate: $5.87
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Albemarle (NYSE:ALB) Dividend Information
|Dividend Growth:||5.90% (3 Year Average)|
|Payout Ratio:||279.17% (Trailing 12 Months of Earnings) |
26.22% (Based on This Year's Estimates)
23.30% (Based on Next Year's Estimates)
|Track Record:||14 Years of Consecutive Dividend Growth|
Albemarle (NYSE:ALB) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Albemarle (NYSE ALB) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.74%
Institutional Ownership Percentage: 86.42%
Albemarle (NYSE ALB) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|8/24/2017||Matthew Juneau||EVP||Sell||5,397||$115.77||$624,810.69||360|| |
|8/23/2017||Karen G Narwold||EVP||Sell||11,500||$115.95||$1,333,425.00||36,620|| |
|7/7/2017||Luther C Iv Kissam||Chairman||Sell||50,000||$110.08||$5,504,000.00||252,917|| |
|7/7/2017||Scott Tozier||CFO||Sell||25,000||$110.13||$2,753,250.00||57,506|| |
|6/19/2017||Douglas L Maine||Director||Sell||10,000||$107.94||$1,079,400.00||24,150|| |
|6/19/2017||Karen G Narwold||EVP||Sell||20,000||$108.16||$2,163,200.00||45,120|| |
|1/6/2017||Karen G Narwold||EVP||Sell||392||$90.59||$35,511.28||22,284|| |
|1/6/2017||Luther C Iv Kissam||Chairman||Sell||2,542||$90.46||$229,949.32||190,628|| |
|1/6/2017||Scott Tozier||CFO||Sell||1,057||$90.62||$95,785.34||29,722|| |
|12/6/2016||Karen G Narwold||EVP||Sell||10,000||$86.11||$861,100.00||31,108|| |
|8/24/2016||Luther C Iv Kissam||CEO||Sell||50,000||$83.19||$4,159,500.00||233,000|| |
|8/5/2016||John Sherman Jr||Director||Sell||4,300||$82.09||$352,987.00||1,500|| |
|5/12/2016||Donald J Jr. Labauve||CAO||Sell||3,564||$75.34||$268,511.76||3,464|| |
|5/12/2016||John Sherman Jr||Director||Sell||2,025||$75.73||$153,353.25||1,850|| |
|5/12/2016||Matthew Juneau||SVP||Sell||13,174||$75.34||$992,529.16||360|| |
|3/14/2016||Karen G Narwold||SVP||Sell||405||$60.38||$24,453.90||21,108|| |
|3/8/2016||Scott Tozier||CFO||Sell||556||$58.89||$32,742.84||28,665|| |
|3/1/2016||Luther C Iv Kissam||CEO||Sell||1,048||$57.98||$60,763.04||191,103|| |
|1/6/2016||Karen G Narwold||SVP||Sell||138||$52.57||$7,254.66||19,893|| |
|1/6/2016||Scott Tozier||CFO||Sell||190||$52.55||$9,984.50||26,998|| |
|9/1/2015||Luther C. Iv Kissam||CEO||Buy||4,533||$44.01||$199,497.33||170,777|| |
|3/2/2015||Luther C Iv Kissam||CEO||Sell||1,075||$56.36||$60,587.00|| |
|2/11/2015||James J /Ky Obrien||Director||Buy||1,000||$52.68||$52,680.00|| |
|2/3/2015||John Sherman Jr||Director||Buy||2,500||$48.49||$121,225.00|| |
|2/2/2015||Jim W Nokes||Director||Buy||3,000||$47.47||$142,410.00|| |
|1/30/2015||Douglas L Maine||Director||Buy||7,847||$48.48||$380,422.56|| |
|9/12/2014||Gerald A Steiner||Director||Buy||1,000||$64.21||$64,210.00|| |
|8/1/2014||D Michael Wilson||SVP||Buy||5,000||$61.29||$306,450.00|| |
|2/25/2014||Karen Narwold||VP||Sell||2,200||$64.41||$141,702.00||15,388|| |
|2/25/2014||Scott Tozier||CFO||Sell||3,509||$64.44||$226,119.96||28,473|| |
|1/30/2014||John Sherman, Jr.||Director||Sell||1,000||$65.27||$65,270.00||1,600|| |
|1/30/2014||Matthew Juneau||SVP||Sell||5,000||$64.84||$324,200.00||6,519|| |
|1/8/2014||Luther Iv Kissam||CEO||Sell||3,180||$64.41||$204,823.80||160,779|| |
|1/8/2014||Scott Tozier||CFO||Sell||1,339||$64.35||$86,164.65||31,403|| |
Albemarle (NYSE ALB) News Headlines
Albemarle (NYSE:ALB) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Albemarle (NYSE:ALB) Income Statement, Balance Sheet and Cash Flow Statement
Albemarle (NYSE ALB) Stock Chart for Sunday, March, 18, 2018